HM Payson & Co’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$897K Sell
14,008
-394
-3% -$25.9K 0.01% 236
2026
Q1
$1.03M Buy
14,402
+348
+2% +$27.4K 0.01% 224
2025
Q4
$1.15M Sell
14,054
-1,809
-11% -$141K 0.02% 201
2025
Q3
$1.19M Sell
15,863
-7,461
-32% -$556K 0.02% 199
2025
Q2
$1.73M Sell
23,324
-9,226
-28% -$642K 0.03% 153
2025
Q1
$2.63M Sell
32,550
-1,198
-4% -$103K 0.05% 139
2024
Q4
$2.64M Sell
33,748
-918
-3% -$78K 0.04% 135
2024
Q3
$3.25M Sell
34,666
-7,301
-17% -$613K 0.06% 132
2024
Q2
$3.27M Buy
41,967
+3,110
+8% +$254K 0.06% 129
2024
Q1
$3.53M Buy
38,857
+556
+1% +$46.3K 0.07% 127
2023
Q4
$2.96M Sell
38,301
-9,756
-20% -$683K 0.06% 130
2023
Q3
$3.27M Buy
48,057
+32,176
+203% +$2.34M 0.08% 120
2023
Q2
$1.29M Buy
15,881
+9,396
+145% +$750K 0.03% 172
2023
Q1
$532K Buy
+6,485
New +$463K 0.01% 243

Other funds holding GEHC

HM Payson & Co's GEHC Position: Q2 2026 in Review

HM Payson & Co reduced its GE HealthCare (GEHC) stake by 2.7% in Q2 2026, selling an estimated $25.9K and leaving 14,008 shares worth $897K. The position accounts for 0.01% of the portfolio, ranked #236.

HM Payson & Co first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $3.53M in Q1 2024. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • HM Payson & Co held 14,008 shares of GE HealthCare worth $897K as of Q2 2026.
  • HM Payson & Co sold 394 GE HealthCare shares in Q2 2026, an estimated $25.9K.
  • GE HealthCare made up 0.01% of HM Payson & Co's portfolio in Q2 2026, its #236 holding.
  • HM Payson & Co first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • HM Payson & Co's GE HealthCare position peaked at $3.53M in Q1 2024.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.